STIM2 and breast carcinoma: STIM1 and STIM2 were upregulated in MCF-7 breast cancer cells, which enhance the migration and invasiveness ability via STIM2-NFAT1-TGFβ1 pathway promotion on its epithelial-mesenchymal transition (EMT) phenotype [53].